Science journalism by Leonid Schneider, on research integrity and academic publishing in life sciences and biomedicine
Sir Martin Evans, winner of Nobel prize 2007, founded in 2009 the stem cell start-up Celixir, together with a struck-off dentist Ajan Reginald. With the help of the British heart surgeon Stephen Westaby, they ran a very profitable clinical trial in Greece, which now moved into UK.
The 2008 Lancet paper of Paolo Macchiarini and Martin Birchall about the world first trachea transplant might end up retracted. Until recently, the journal’s editor Richard Horton used to ignore and suppress “non peer-reviewed” evidence, but due to combined pressure of activism, media and politics, things started to move.
In yet another investigation, UCL whitewashed Martin Birchall of all responsibilities. I publish here the confidential report and excerpts from a secret PhD thesis, which the UCL committee carefully avoided to read.
The trachea-transplanting company Videregen, based in Liverpool, got another £2 million grant from UK governmental agency Innovate UK, to advance their tracheal replacement technology.
Manipulated data in 17 papers from one cancer research lab in China gets flagged on PubPeer. It ends with the university hospital in Wuhan issuing a secret statement accusing the US pharma giant a Merck of a conspiracy to slander a Chinese Academy member, Dr Ding Ma.
The team around the paediatric oncologist Nabil Ahmed at Baylor College of Medicine in Houston, Texas, discovered a way to engineer T-leukocytes to bypass the blood-brain barrier at attack otherwise untreatable brain cancers. Their amazing technology to get this published in Nature was brazenly insolent data fakery.
Professor Ruben Plentz chose to focus his career on clinical medicine in Bremen, despite his tremendous academic achievements in cancer research. Was it because malicious critics harassed him with frivolous investigations and corrections, envious at all those peer-reviewed cancer cures the great doctor invented?
A decision was announced by the Swedish Prosecution Authority in Gothenburg on the Paolo Macchiarini case today. The issue are plastic trachea transplants the scandal surgeon performed at the hospital of the Karolinska Institutet (KI) in Stockholm, Sweden. The earlier decision by state prosecutor was changed in part and the preliminary investigation will be reopened
Paediatric surgeon Paolo De Coppi claims to grow all possible internal organs in his lab at UCL. Though his career started with his association with Macchiarini, and their regenerative medicine ideas sound strangely similar, De Coppi is celebrated as a modest genius poised to save lives of uncounted children, and the funding money flows.
First gene-edited human babies were allegedly born, two twin girls. Jiankui He, associate professor at the South University of Science and Technology of China claimed to have used CRISPR gene editing technology, in a registered clinical trial, to make babies resistant to HIV. Did this really happen? In any case, everyone now takes distance to He.
